EXAGEN INC. (XGN) Social Stream
Exagen Inc (XGN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering XGN.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
XGN's average price target has moved down $6.2 over the prior 42 weeks.
Over the past 48 weeks, XGN's average upside potential has been 97.52%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
XGN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 151 days, XGN's average broker recommendation rating improved by 0.33.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, Exagen Inc's upside potential (average analyst target price relative to current price) is higher than 347.97% of them.
- In terms of how Exagen Inc fares relative to all US stocks, note that its number of analysts covering the stock is greater than 111.88% of that group.
- In the context of all US stocks, Exagen Inc's average analyst price target is greater than 113.94% of them.
- In terms of how Exagen Inc fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -29.33% of that group.
Is XGN a Buy, Hold or Sell? See the POWR Ratings now!